Navigation Links
Synchrotron radiation illuminates how babies' protective bubble bursts
Date:11/6/2007

Researchers at the University of Reading, School of Pharmacy have developed an important new technique to study one of the most common causes of premature birth and prenatal mortality. The findings are published in the November 7 issue of the online, open-access journal PLoS ONE.

Dr Che Connon, a Research Councils UK Fellow in Stem Cells and Nanomaterials, and his team used a powerful X-ray beam to examine tiny structures within the protective sac - amniotic membrane - which surrounds the developing baby.

This beam can resolve structures far smaller than a light or electron microscope. Furthermore, unlike other more intrusive forms of microscopy, X-ray investigation requires no processing of the tissue before examination, so can produce an accurate measurement of amniotic membrane structure in its normal state.

When the protective sac raptures during labour this is when the mothers waters burst; if premature rupture occurs it can result in death or mental retardation of the child. Currently premature birth is increasing and 40% are attributed to the early rupture of amniotic membranes. Thus, a better understanding of the rupture process will lead to better treatment, earlier diagnosis and fewer premature deliveries

Dr Connon, an expert in tissue structure, said: This is of interest to the general public because amniotic membrane rupture is an important stage in the start of labour. More importantly early rupture of the amniotic membranes occurs in up to 20% of all pregnancies worldwide, and is the most common cause of preterm birth, leading to babies dying or having major problems such as cerebral palsy. The paper describes a new breakthrough in understanding the structure of amniotic membranes and how they rupture. Hopefully this will lead to therapies designed to prevent preterm membrane rupture as well.

Rupture of amniotic sac has been associated with a weakening of the tissue, but there is very little informati
'/>"/>

Contact: Che Connon
c.j.connon@reading.ac.uk
44-118-378-7053
Public Library of Science
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
2. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
3. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
4. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
5. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...ggests Wisconsin is slowly making progress when it...judged by indicators such as producing patents, in...reating high-tech jobs. The natural question: Why ...ut a variety of factors promise more progress pro...ion. , ,The report, commissioned by the Wisconsin...
...olumn over the last few years knows about my prope...e information into tidy boxes in some meaningful o...out of the information for myself). While my list ...ow enlightened me about how lists could be used to...n one of my companies, I even adapted the Letterma...
...y to pick up a pizza the other night. I ran into ...rbis, the massive digital image library. Doug is...g product for digital pictures. , ,If, like me, yo...red on your mobile phone the moment for sharing ha...package provides everything you need to create a t...
...chnology-wise has already been invented. I,ve been...last 15 years about technology innovation, and the... all that innovation. From a quick look into the i...ular soapbox is getting crowded. Pick up any indus...ons about process, best practices, business alignm...
Other Biology Technology:Heres why Wisconsins tech economy indicators are up 2Heres why Wisconsins tech economy indicators are up 3Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 2Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 3Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 4ZoomAlbum operates virtually 2ZoomAlbum operates virtually 3The end of technology history 2The end of technology history 3
(Date:10/6/2008)...722; The American Physiological Society has establ...estricted grants of up to $2,000 to support physio...o suffered losses as a result of Hurricane Ike. Th...nd also affected other areas of the country. , T... are either APS members or working in the laborato...
(Date:10/5/2008)...rnal of Cell Biology how the altered behavior of ...cells., On 2D surfaces, cells may migrate randoml... link the cell to the extracellular matrix, are kn...y how has been unclear. Recent work has suggested ...t, while an integrin called avb3 has been associat...
(Date:10/5/2008)...sts report online this week in Nature that they ...ells to a gene associated with Crohn,s disease, an...lammatory bowel disorder. , The link to immune c...y School of Medicine in St. Louis because they and...rected immune responses in the intestine that dama...
(Date:10/3/2008)...008)Researchers from Harvard Medical School and th...how beetles and bacteria form a symbiotic and mutu... the destruction of pine forests. In addition, the...this whole phenomenon. , The context of this di... includes some of the most unlikely characters and...
Breaking Biology News(10 mins):Form of Crohn's disease traced to disabled gut cells 2Cross kingdom conflicts on a beetle's back 2Cross kingdom conflicts on a beetle's back 3Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 517 1Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 517 2Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 1Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 2Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 3Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 4Cryo Cell International Inc Reports Third Quarter 2007 Results 3697 5Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 1Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 2Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 3Nyer Medical Group Inc Reports EPS of 24 02 on Record Revenues of 2469 9 Million for Fiscal Year Ended 2007 3692 4Americas Top Hospitals Are Real Lifesavers 3690 1Americas Top Hospitals Are Real Lifesavers 3690 2
...have discovered a vast network of neurons in the b...s the effects of reproductive status on other brai...ound neural circuits that coordinate a complex int...nd brain areas that carry the neural signals trigg...heromones, chemical signals produced by animals. T...
...ntified two new genes that operate as regulators i...ococcus aureus , one of the bacteria most frequent...ts, and has explained the functioning of a structu... was the subject of a PhD thesis recently defended...IC and Public University of Navarra centre, and is...
...ngi, such as white rot, are particularly harmful f... Soil samples are investigated to detect this; a l...with the Laboratory for Nematology (University of ...ular technique to detect the stem nematode and whi... Blgg will start using the new system in November ...
...herapy (HAART) for HIV infection remain susceptibl...or HIV-infected patients not on HAART, according t...ctious Diseases, now available online. , Opportun...fatal for immunocompromised patients. HAART not on...n helps to keep other infections such as TB under ...
Other Biology News:The brain is broadly wired for reproduction 2The brain is broadly wired for reproduction 3The brain is broadly wired for reproduction 4The brain is broadly wired for reproduction 5Genes involved in biofilms 2DNA technique measures suitability of soil for onion crops 2Tuberculosis still a risk for patients receiving HIV drugs 2
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum.
...EnzChek Pyrophosphate Detection Kit,provides a fas...ethod for measuring the inorganic pyrophosphate (P..., such as DNA and,RNA polymerizations, cyclic AMP ...enzymatic activation of fatty acids to,form their ...
...ose Gel-Digesting Preparation contains a unique &b...RE for simple, quantitative recovery of intact DNA... following electrophoresis in TAE, TBE, MOPS, or p... in the TAE, TBE, MOPS, and phosphate electrophore...
Request Info
Biology Products: